Assessment of Automatic Tourniquets for Soldiers During Wartime
NCT ID: NCT06123104
Last Updated: 2024-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
10 participants
INTERVENTIONAL
2023-10-27
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Are AUTs effective in occlusion of blood flow
* Are AUTs easy to use
Participants will be asked to place AUT and CAT on their upper limbs and lower limbs (8 applications overall).
Following each application, the following parameters will be assessed:
1. Limb blood flow
2. Ease of use
Researchers will compare the results of the AUT and CAT to see if AUT is as effective as CAT in blood occlusion, and if AUT is easy to use as the CAT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
LAVA TQ Doppler Functionality Study
NCT05504733
Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
NCT03152461
Clinical Application and Validation of Innovative Tourniquet
NCT05605990
Survey of Tourniquet Use in a Combat Support Hospital
NCT00517166
Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma
NCT03934983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Are AUTs effective in occlusion of blood flow
* Are AUTs easy to use
Participants will be asked to place AUT and CAT on their upper limbs and lower limbs (8 applications overall).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Automatic Tourniquet
Automatic pneumatic tourniquet
Occlusion of blood flow diagnosed by Point of Care UltraSound (POCUS)
Tourniquets will be applied until peripheral blood flow occlusion is achieved. Total intervention time: up to 60 seconds
Combat Application Tourniquet (CAT)
Combat Application Tourniquet Generation 7
Occlusion of blood flow diagnosed by Point of Care UltraSound (POCUS)
Tourniquets will be applied until peripheral blood flow occlusion is achieved. Total intervention time: up to 60 seconds
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Occlusion of blood flow diagnosed by Point of Care UltraSound (POCUS)
Tourniquets will be applied until peripheral blood flow occlusion is achieved. Total intervention time: up to 60 seconds
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Peripheral nerve disorders
* Skin diseases of the limbs
* Limb surgery in the past
* Rickets
* Hypertension
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Corps, Israel Defense Force
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
TOMER ERLICH
Head of Innovation, R&D Directorate, IDF Medical Corps Head of Medical Research, Directorate of Defense R&D, Israeli Ministry of Defense (IMOD DDR&D)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomer Erlich, MD
Role: PRINCIPAL_INVESTIGATOR
Head of Medical innovation and R&D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel hashomer
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1.1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.